The loss of PRMT1 in ECs led to pulmonary hemorrhage, compromised barrier function, increased inflammation, and fibrosis, all of which are hallmarks of COPD‐related vascular pathology. Here, PRMT1 is linked to Pulmonary hemorrhage.